Претрага

Резултати

Cardiovascular outcomes associated with achieved haemoglobin level and preliminary rate of rise of haemoglobin in pooled phase 3 studies of roxadustat in non-dialysis-dependent patients with anaemia [2021]

Barratt, Jonathan; Sulowicz, Wladyslaw; Cockburn, Elinor; Reusch, Michael; Young, James; Dimkovic, Nada B

Obesity - risk factor for doctors' health [2009]

Vukadinovic, Nada; Cimbaljevic, Branko

Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110 [2020]

Herbst, Roy S; ...; Andric, Zoran G ; ...; (broj, koautora 21)

Randomized, double-blind, phase II study of tiragolumab plus atezolizumab versus placebo plus atezolizumab as first-line treatment for PD-L1-selected NSCLC (CITYSCAPE) [2020]

Rodriguez-Abreu, Delvys; ...; Secen, Nevena M; ...; (broj, koautora 21)

Prevalence of SARS-CoV-2 positivity in infants with bronchiolitis: a multicentre international study [2022]

Cozzi, Giorgio; ...; Gojšina, Bojana; ...; Sovtić, Aleksandar D.

Lymphopenia is highly prevalent in MDS and provides prognostic information for IPSS-R (very)-low-risk patients. An analysis from the EU-MDS registry [2021]

Silzle, T; ...; Savic, Aleksandar D ; ...; (broj, koautora 20)

Body mass index and atopic disease [2008]

Cerovic, Sofija; Zivkovic, Zorica M; Radic, Snezana D; Jocic-Stojanovic, Jasmina; Rodic, V; Bajec-Opancina, Aleksandra A; Gavrilovic, T; Veljkovic, P

Body mass index and asthma severity [2008]

Joci-Stojanovic, Jasmina; Zivković, Zorica M.; Radić, Snežana D.; Cerović, Snežana J ; Rodić, V; Bajec-Opančina, Aleksandra A.; Gavrilović, T; Veljković, P

Roxadustat for the treatment of anemia in chronic kidney disease (CKD) patients not on dialysis (NDD): a phase 3, randomized, open-label, active-controlled study [2020]

Barratt, Jonathan; Andric, Branislav R; Tataradze, Avtandil; Schoemig, Michael; Reusch, Michael; Valluri, Udaya

Pooled efficacy and cardiovascular safety results of roxadustat compared with placebo/ darbepoetin alfa for treatment of anaemia in patients with non-dialysis-dependent (NDD) chronic kidney disease (CKD) [2021]

Barratt, Jonathan; Dimkovic, Nada B; Shutov, Evgeny; Sulowicz, Wladyslaw; Esposito, Ciro; Reusch, Michael; Young, James; Mariat, Christophe